CCc1nn(CC(=O)NCCCN(CC(C)C)CC(C)C)c(=O)c2cc3sc(C)cc3n12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?